DEADLINE EXTENDED TO JANUARY 31, 2022!
The Lobular Breast Cancer Alliance is pleased to announce that online applications are being accepted for the 2022 Conquer Cancer – Lobular Breast Cancer Alliance Young Investigator Award (YIA) for Invasive Lobular Carcinoma Research. This unique grant will provide $100,000 in funding over two years to a promising young physician scientist whose research will focus on invasive lobular carcinoma (ILC).
ILC is a challenging and understudied form of breast cancer. The purpose of the Young Investigator Award is to fund physicians during the transition from a fellowship program to a faculty appointment, providing critical support needed to establish an impactful career in ILC research. Conquer Cancer welcomes application submissions only from investigators who are committed to conducting translational and clinical ILC research.
“We are so excited to be working with Conquer Cancer, the ASCO Foundation for a second time to offer another Young Investigator Award for Invasive Lobular Carcinoma Research,” commented LBCA Executive Director Laurie Hutcheson. “We are able to make great strides towards eradicating ILC by making grants that focus explicitly on ILC and attract new researchers to focus on better understanding the deadly puzzle that ILC, the sneaky breast cancer, presents.”
Interested researchers have until January 10, 2022, to submit their online applications. More information can be found at 2022 Conquer Cancer – Lobular Breast Cancer Alliance Young Investigator Award for Invasive Lobular Carcinoma Research. The award winner will be notified in April 2022 with the grant in effect from July 1, 2022, to June 30, 2024.
# # #
About Lobular Breast Cancer Alliance: As the only organization in the US dedicated to Invasive Lobular Breast Cancer (ILC), LBCA’s mission is to make all who are touched by ILC aware of its unique characteristics and the critical need for more ILC research; to be the go-to source for information on ILC studies, clinical trials and educational tools; to foster partnerships among patients, scientists, clinicians, and breast cancer organizations to increase dialogue about ILC and research advocacy; and to fund vital ILC research. For more information, visit lobularbreastcancer.org.
About Conquer Cancer Conquer Cancer: The ASCO Foundation, funds research for every cancer, every patient, everywhere. In 1964, seven oncologists created the American Society of Clinical Oncology (ASCO), now a global network of nearly 45,000 cancer professionals. As ASCO’s foundation, we support groundbreaking research and education so both doctors and patients have the resources they need. For more information, visit CONQUER.ORG.
